PSY4 Budget Impact of Baricitinib for Moderate-to-Severe Atopic Dermatitis Patients with an Inadequate Response to Topical Treatments
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.1145
https://www.valueinhealthjournal.com/article/S1098-3015(21)01362-0/fulltext
Title :
PSY4 Budget Impact of Baricitinib for Moderate-to-Severe Atopic Dermatitis Patients with an Inadequate Response to Topical Treatments
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01362-0&doi=10.1016/j.jval.2021.04.1145
First page :
Section Title :
Open access? :
No
Section Order :
10636